Tanaleon, Jenelyn .

HRN: 24-15-56  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2024
AMPICILLIN 1GM (VIAL)
12/14/2024
12/15/2024
IVT
2g
Q6hrs
G1P0; Thickly MSAF
Waiting Final Action 
12/14/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/14/2024
12/15/2024
IVT
500mg
Q8
G1P0; Thickly MSAF
Waiting Final Action 
12/14/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/14/2024
12/16/2024
IVT
900
Q6
S/p Primary LTCS
Waiting Final Action 
12/14/2024
GENTAMICIN 40MG/ML, 2ML (AMP)
12/14/2024
12/16/2024
IVT
160 MG
OF
S/P LTCS
Waiting Final Action 
12/14/2024
CEFUROXIME 500MG (TAB)
12/14/2024
12/21/2024
PO
500 MG
BID
S/P PRIMARY LTCS
Waiting Final Action 
12/14/2024
MUPIROCIN 2%, 15G (TUBE)
12/14/2024
12/28/2024
TOPICAAL
Pea Size
OD
LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: